MedTrace Logo

The Effect of Tranexamic Acid on Postpartum Hemorrhage During and After Cesarean Delivery

NCT01085006 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2011-01-25

Study results available
· View outcomes & findings →

Summary

Intravenous Tranexamic acid is used to reduce the hemorrhage during and after cesarean delivery in a double blind randomized placebo controlled trial.

Conditions

Interventions

DRUG

Tranexamic acid

Tranexamic acid in cases, normal saline in controls

DRUG

Normal saline

Tranexamic acid in cases, normal saline in controls

Sponsors & Collaborators

  • Tehran University of Medical Sciences

    lead OTHER

Principal Investigators

  • Laleh Eslamian, MD · Associated Prof, Obstetrician & Gynecologist

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2010-08-31
Completion
2010-09-30

Countries

  • Iran

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01085006 on ClinicalTrials.gov